Uppsala Monitoring Centre

YouTube video by Uppsala Monitoring Centre The WHO PIDM in Focus - Colombia

🎥 Since 2019, Invima Colombia has used #VigiFlow as its national safety surveillance database to monitor the safety of #medicines and #vaccines in Colombia🇨🇴.

See how VigiFlow and connected applications help develop a robust #pharmacovigilance database in the film below👇

Temporal Changes in Reporting of Neurodevelopmental Outcomes After Maternal Exposure to Valproate: A Contribution of the ConcePTION Project - Drug Safety Background Understanding changes over time in the quantity and characteristics of reports submitted to pharmacovigilance centres is crucial for accurately interpreting safety signals associated with e...

📖 A new #OpenAccess article underscores the importance of temporal changes in reporting to accurately interpret pregnancy-related safety signals.
Learn more about neurodevelopment outcomes following maternal exposure to #valproate at the link below👇

This #WorldBreastfeedingWeek, we're looking back to #MedSafetyWeek 2018🤱

If you're #pregnant or #breastfeeding, speak to your doctor about the medicines you're taking, as many can affect infants and foetuses in different ways.

Read up on the #MedSafetyWeek campaign here 👉 ow.ly/XEoc50LlhaJ

Making medicines safer for pregnant and breastfeeding women Pregnancy and breastfeeding can be a chaotic period, exacerbated by lack of safety information for drugs taken during this time. The IMI ConcePTION project aims to change that.

Roughly 5% of drugs on the market have been labelled with meaningful safety information for #pregnancy and #breastfeeding.

This #WorldBreastFeedingWeek, learn how initiatives like IMI ConcePTION aim to close the knowledge gap and make medicines safer in #UppsalaReports👇

Signals of Adverse Reactions to Herbal Medicines: Evidence and Document Analysis Based on a Scoping Review - Drug Safety Background To date, signals of adverse reactions to herbal medicines have not been systematically reviewed, limiting pharmacovigilance of herbal medicines because of a lack of data. Objectives We soug...

Based on a scoping review, UMC researchers and colleagues at @cebmoxford.bsky.social examine the evidence of signals involving herbal medicines and compare documentation made available to healthcare professionals and patients in the EU🇪🇺 and the USA🇺🇸.

#OpenAccess at the link below👇

YouTube video by Uppsala Monitoring Centre My Med Safety Story: Mexico

🎥 𝙒𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙮𝙤𝙪?

Since 2016, we've teamed up with #pharmacovigilance stakeholders worldwide for the #MedSafetyWeek campaign. Armida Zuñiga Estrada, Head of COFEPRIS, shares Mexico🇲🇽's Med Safety Story in the film below 👇
youtube.com/shorts/5qulN...

Artificial intelligence in pharmacovigilance: Harnessing potential, navigating risks AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.

The role of #AI in medicines safety is constantly evolving. However, to fully harness its potential, there is a greater need to navigate the risks first.

Niklas Norén writes how we should critically assess AI in #UppsalaReports👇
uppsalareports.org/articles/art...

Uncovering Pregnancy Exposures in Pharmacovigilance Case Report Databases: A Comprehensive Evaluation of the VigiBase Pregnancy Algorithm - Drug Safety Background Information on the safety of medicine use during pregnancy is limited at the time of marketing, making post-marketing surveillance essential. However, the lack of a specific indicator for p...

One challenge of #pharmacovigilance is retrieving case reports involving #pregnancy. UMC researchers demonstrate the robustness of an algorithm in uncovering pregnancy-related cases in VigiBase in this #DrugSafety article.

📖 #OpenAccess below👇
doi.org/10.1007/s402...

We hope you've enjoyed following #MedicationErrorsFridays as we've explored the critical stages, vulnerable populations, & other areas where errors can occur, such as #MedicalDevices.

Be sure to read #UppsalaReports for more on #MedicationErrors 👉 ow.ly/F4q150W5qYF

Stay informed about all things #pharmacovigilance by listening to our podcast #DrugSafetyMatters. Some of our latest episodes cover:

🗣️ Patient perspectives in PV
📝 Quality in ADR reporting
🫄 Pregnancy-related pharmacovigilance

🎧 Listen now at 👉 www.drugsafetymatterspod.org

🩺 Diagnostics

Mistakes in diagnostic processes, like misinterpreting test results, which can lead to incorrect treatment plans.

💊 Supplements

Issues arising from the use of dietary supplements, including interactions with prescribed medications.

🩸 Medical devices

Errors related to the use of devices like infusion pumps, insulin pens, or inhalers.

💉 Vaccines

Errors can occur in the storage, handling, or administration of vaccines.

𝘋𝘪𝘥 𝘺𝘰𝘶 𝘬𝘯𝘰𝘸? #MedicationErrors aren't limited to just medicines. They can occur in these areas as well:

💉 Vaccines
🩸 Medical devices
💊 Supplements
🩺 Diagnostics

We go beyond medicines in the thread below👇

Get the full scope of medication errors in #UppsalaReports 👉 ow.ly/F4q150W5qYF

𝙎𝙞𝙙𝙚 𝙚𝙛𝙛𝙚𝙘𝙩𝙨 𝙙𝙤𝙣'𝙩 𝙩𝙖𝙠𝙚 𝙫𝙖𝙘𝙖𝙩𝙞𝙤𝙣 🏖️

If you find yourself by the water this summer, remember to #ReportSideEffects to your healthcare professional. Enjoy the sun safely, like our blobs from #MedSafetyWeek 2020 and 2023.

Learn more 👉 ow.ly/XEoc50LlhaJ

Winning the war against health mis and disinformation Public health is at risk now more than ever; with AI it has never been easier to spread mis- and disinformation on health. How do we work smarter to address this threat?

Since the COVID-19 pandemic, health-related mis- and #disinformation have increased dramatically alongside a broader decline in public trust in institutions.

Sahil Shah tells us how to win the war against health #misinformation in #UppsalaReports👇

👦🏽 Administration errors

Mistakes can occur in how medications are administered, such as inaccurately measuring liquid doses or ensuring children take their full dose.

👧🏼 Dispensing challenges

Medications prescribed for children often require precise calculations based on age, size, and weight, increasing the risk of dosing errors.

🧒🏻 Lack of paediatric guidelines

Many medications do not have specific dosing guidelines for children, making it difficult to determine the correct dose.

Children are more vulnerable to #MedicationErrors due to unclear dosing guidelines and a lack of child-specific medications.

Learn more about the factors impacting child patients in the thread below👇 and read our #DeepDive for more 👉 ow.ly/F4q150W5qYF

#paediatrics #pharmacovigilance

📩 Our #UppsalaReports newsletter brings the latest updates from the world of pharmacovigilance straight to your inbox. Stay informed about activities in the WHO PIDM, trending tools & technology, exciting new research, & PV-related events around the globe.

Subscribe 👉 uppsalareports.org/subscribe

#Pharmacovigilance will need to engage patients in diverse ways to ensure future safety.

🎧 Listen to Angela Caro Rojas and panellists discuss patient perspectives in PV in this special episode of #DrugSafetyMatters, recorded at the ISoP Mid-Year Symposium #ISoPUppsala2025 👉 ow.ly/lRhN50WgWhy

YouTube video by Uppsala Monitoring Centre My Med Safety Story: Iraq

🎥 𝙒𝙝𝙖𝙩 𝙙𝙤𝙚𝙨 #𝙈𝙚𝙙𝙎𝙖𝙛𝙚𝙩𝙮𝙒𝙚𝙚𝙠 𝙢𝙚𝙖𝙣 𝙩𝙤 𝙮𝙤𝙪?

Since 2016, we've teamed up with #pharmacovigilance stakeholders worldwide for the #MedSafetyWeek campaign. Watch the film below to hear our colleagues in Iraq🇮🇶 share their Med Safety Story👇

💊 Mixing medications

Taking prenatal vitamins, supplements, and prescribed medications together can cause unexpected reactions.

💊 Physical changes

Changes in the body during pregnancy can affect how medications are processed, leading to incorrect dosages.

💊 Harm to the unborn baby

Some medications can cause birth defects or developmental issues in the foetus.

🤰🏾Pregnant patients are especially vulnerable to #MedicationErrors due to the potential impact on the patient's health and unborn baby.

Learn more about the factors impacting pregnant patients in the thread below👇 and read our #DeepDive for more 👉 ow.ly/F4q150W5qYF

YouTube video by Uppsala Monitoring Centre The WHO PIDM in Focus - Iraq & Jordan

🎥 How is #VigiFlow shaping pharmacovigilance across the @who.int PIDM?

Manal Younus and Jaber Jaber share how they’re utilising VigiFlow and connected applications to monitor the safety of medicines and vaccines in Iraq🇮🇶 and Jordan🇯🇴.

Watch the film below for more👇

💊 Adherence to complicated medication regimens

Complex medication schedules can lead to missed or double doses.